当前位置：首页 > 文献互助 > 互助详情

期刊论文A first-in-human phase 1/2 dose-escalation study of MAK683 (EED inhibitor) in patients with advanced malignancies复制

用户7nEFK6amBq5Y 2个月前 152 已关闭

文献链接:复制

其他信息:

互助时间线

楼主用户7nEFK6amBq5Y关闭了求助

The Pigmentation of Blue Light Is Mediated by Both Melanogenesis Activation and Autophagy Inhibition through OPN3–TRPV1 8分钟前

Design principles of catalytic reactive membranes for water treatment 1小时前

Characterization of preclinical radio ADME properties of ARV-471 for predicting human PK using PBPK modeling 10小时前

Molecular glues that facilitate RAS binding to PI3Kα promote glucose uptake without insulin 11小时前

Profiling and Optimizing Targeted Covalent Inhibitors through EGFR-Guided Studies 12小时前

Exogenous RNA surveillance by proton-sensing TRIM25 12小时前

Chemical Posttranslational Modification of Phage-Displayed Peptides 13小时前

Synthesis and Screening of One-Bead-One-Compound Cyclic Peptide Libraries 13小时前